Table 3 Frequency of patients who discussed each decision box topic in each participating primary healthcare clinic
Decision box clinical topics (abbreviations) | Clinics | Number patients | % patient (n = 37) | |||
|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||
Statins for primary prevention of cardiovascular disease (Statins) | 0 | 1 | 7 | 3 | 11 | 30 |
The fecal occult blood test to screen for colorectal cancer (FOBT) | 2 | 0 | 6 | 0 | 8 | 22 |
Bisphosphonates to prevent osteoporotic fractures in postmenopausal women (OSTEO) | 1 | 1 | 3 | 1 | 6 | 16 |
Acetylsalicylic acid for primary prevention of cardiovascular disease (ASA) | 2 | 0 | 3 | 0 | 5 | 14 |
The BRCA1/2 gene mutation test to evaluate the risks of breast and ovarian cancer (BRCA) | 1 | 2 | 0 | 0 | 3 | 8 |
The serum integrated test to screen women for fetal trisomy 21 (Prenatal) | 2 | 0 | 0 | 0 | 2 | 5 |
The prostate-specific antigen test to screen men for prostate cancer (PSA) | 0 | 0 | 2 | 0 | 2 | 5 |
Cholinesterase inhibitors to reduce the symptoms of Alzheimer’s disease (ChEIs) | 0 | 0 | 0 | 0 | 0 | 0 |